Wagner Wealth Management (South Carolina)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Wagner Wealth Management (South Carolina)'s IBB Position: Q2 2026 in Review
Wagner Wealth Management (South Carolina) sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 35 shares — an estimated $5.91K sold.
Wagner Wealth Management (South Carolina) first reported a position in IBB in Q4 2017 and held it in 20 quarters. The position peaked at $90K in Q1 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Wagner Wealth Management (South Carolina) reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
- Wagner Wealth Management (South Carolina) sold 35 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.91K.
- Wagner Wealth Management (South Carolina) first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 20 quarters.
- Wagner Wealth Management (South Carolina)'s iShares Biotechnology ETF position peaked at $90K in Q1 2022.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q2 2026, filed 24 Jul 2026.